Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gary Pace | M | 76 |
Upstream Medical Technologies Ltd.
 Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | - |
| Judith Swain | M | 75 |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | - |
| Roland Toder | M | - |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | - |
| Colin Ernest Dawson | M | - |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | 9 years |
| Kieran Craig Jina | M | - |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | 5 years |
| David Christensen | M | - |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| New Zealand | 6 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Chris Pemberton
- Personal Network